MMD — Milestone Medical Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -20058.33% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.12 | 0.04 | 0.02 | 0.15 | 0.05 | n/a | n/a | 92.41% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Milestone Medical, Inc. develops epidural and intra-articular drug delivery systems based on patented, painless, computer-controlled injection and drug delivery technology. Its CompuFlo Epidural System provides anesthesiologists and other health care providers with the ability to determine and document the pressure at the needle tip in real-time. Its CompuFlo Epidural's DPS Dynamic Pressure Sensing Technology (DPS) allows the CompuFlo Epidural to provide objective visual and audible in-tissue pressure feedback that allows anesthesiologists to identify the epidural space. The DPS instrument is a patented computer-controlled injection system geared to the needs of the medical market. The Company’s is also focused on marketing the Epidural medical and trainer instruments in the United States. The Company’s products include medical instruments, handpieces/disposables, and other related products. It sells its products primarily through medical facilities and a global distribution network.
Directors
- Steven Robins PRE (49)
- Jan Haverhals CEO (60)
- Scott Kahn CFO
- Stephen Solomon GCN
- Joe Bjorklund DSL
- Mark Hochman OTH (60)
- Edward Zelnick OTH (74)
- Martin Siegel DRC (72)
- Zhu Yun DRC
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- March 8th, 2011
- Public Since
- November 28th, 2013
- No. of Employees
- 4
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 22,000,000
- Address
- 425 Eagle Rock Ave, Suite 403, ROSELAND, 07068
- Web
- https://medicalmilestone.com/
- Phone
- +1 9735352717
- Contact
- Justyna Gudaszewska
- Auditors
- Friedman LLP
Upcoming Events for MMD
Similar to MMD
Bioton SA
Warsaw Stock Exchange
Braster SA
Warsaw Stock Exchange
Captor Therapeutics SA
Warsaw Stock Exchange
E-Shopping SA
Warsaw Stock Exchange
Genomed SA
Warsaw Stock Exchange
FAQ
As of Today at 22:03 UTC, shares in Milestone Medical are trading at PLN1.58. This share price information is delayed by 15 minutes.
Shares in Milestone Medical last closed at PLN1.58 and the price had moved by -12.22% over the past 365 days. In terms of relative price strength the Milestone Medical share price has underperformed the FTSE Global All Cap Index by -24.23% over the past year.
There is no consensus recommendation for this security.
Find out moreMilestone Medical does not currently pay a dividend.
Milestone Medical does not currently pay a dividend.
Milestone Medical does not currently pay a dividend.
To buy shares in Milestone Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN1.58, shares in Milestone Medical had a market capitalisation of .
Here are the trading details for Milestone Medical:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: MMD
Based on an overall assessment of its quality, value and momentum Milestone Medical is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Milestone Medical. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -27.07%.
As of the last closing price of PLN1.58, shares in Milestone Medical were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Milestone Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN1.58.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Milestone Medical's management team is headed by:
- Steven Robins - PRE
- Jan Haverhals - CEO
- Scott Kahn - CFO
- Stephen Solomon - GCN
- Joe Bjorklund - DSL
- Mark Hochman - OTH
- Edward Zelnick - OTH
- Martin Siegel - DRC
- Zhu Yun - DRC